- Inflammatory bowel disease is a chronic condition. Certain factors can increase someone’s chances of developing inflammatory bowel disease.
- Researchers are still working to understand inflammatory bowel disease risk factors and the steps people can take to modify potential risk factors.
- Data from a recent study found that antibiotic use was associated with an increased risk of developing inflammatory bowel disease, particularly in adults aged 40 and older.
Inflammatory bowel disease (IBD) is a term that encompasses a number of different conditions which can vary in severity.
Researchers are still trying to understand what increases someone’s risk of developing the condition, which encompasses Crohn’s disease and ulcerative colitis.
A study published in the journal Gut examined the use of antibiotics and the risk for IBD.
While it is understood that antibiotic use can increase the risk of developing IBD in children in the years following use, it was unclear to what degree the risk affected people of different ages. The study’s researchers determined that increased use of antibiotics was associated with an increased risk of developing IBD, especially in adults aged 40 and above.
As its name implies,
Dr. Kenneth Brown, a gastroenterologist in Plano, Texas, who was not involved the new study, explained to MNT:
“Inflammatory bowel disease (IBD) is a group of disorders characterized by chronic inflammation (pain and swelling) in the intestines. Although IBD usually is not fatal, it is a serious condition that can cause life-threatening complications in some cases. Patients suffering from IBD may experience a range of symptoms from mild to severe. Symptoms of IBD can include abdominal pain, diarrhea, fatigue, and weight loss. In severe cases, IBD can lead to complications such as malnutrition, bowel perforation, and cancer.”
The exact cause of IBD is not clear. However, the majority of cases develop in people under the age of 30. People with certain genetics may have an increased risk for IBD.
Researchers are still working to understand how environmental risk factors and lifestyle factors can play a role in IBD development.
As more data emerges about risk factors, experts can continue to make recommendations about how people can reduce their risk for IBD.
This latest study was a population-based cohort study.
The authors wanted to look at how antibiotic use related to the development of IBD in people 10 years old and older. They used Denmark’s nationwide registries to analyze data from more than 6 million individuals. In their data collection, about 50,000 of the participants developed IBD.
Overall, researchers said, antibiotic use was associated with an increased risk of developing IBD. When looking at antibiotic types, they found the risk of developing IBD was highest after receiving antibiotics that doctors often use to treat infections in the gastrointestinal tract.
The main exception to the researchers’ findings was nitrofurantoin, which is frequently prescribed for urinary tract infections. This antibiotic type was not associated with the development of IBD.
Dr. Adam Faye, a study author and inflammatory bowel disease specialist, explained the four main takeaways of the data to MNT:
- Antibiotics are more strongly associated with the development of IBD in older adults (40 and above)
- The more courses of antibiotics, the higher the risk
- Antibiotic use in the 1-2 years prior was associated with the highest risk of developing IBD (but this risk persisted even several years out)
- Antibiotics commonly used to treat gastrointestinal infections were associated with the highest risk of developing IBD.
The study indicates caution in using antibiotics to help avoid possible long-term complications such as IBD.
“Antibiotic stewardship is key- not just important to prevent drug resistance, but also has the potential to limit the development of IBD (particularly in older adults)- thus, important not to just empirically prescribe in cases where antibiotics may not be indicated.”
Brown further noted, “The findings of this study suggest that physicians should be mindful of the potential risks associated with antibiotic use, particularly in older individuals, and should consider alternative treatments when possible.”
The study did have some limitations.
First, the study did not specifically determine that antibiotic use causes IBD. Researchers acknowledge that there is still the possibility of reverse causality and a chance that they missed certain factors.
Second, researchers did not have access to the indications for why participants received the antibiotics that they did. So, there is a chance that a participant’s underlying infection could have contributed to the results.
Finally, researchers only looked at outpatient antibiotic prescriptions. Thus, they could not measure the actual use of antibiotics or how well participants adhered to the proper use of their antibiotic prescriptions.
Further research can examine why there is an apparent associated risk between antibiotic use and IBD.
“We hypothesize that antibiotics are contributing to the development of IBD through modulation of the intestinal microbiome- but this needs further exploration/research,” said Faye.
He added that researchers can “explore environmental factors that contribute to the development of IBD in older adults,” and that “data looking at lifetime use of antibiotics (from birth on) will also add to what we know (looking at cumulative dosing over time).”